Acquiring shares in
Acquiring shares in Polish newspaper
April 27, 2004 04:05 ET | Orkla ASA
Orkla Press now possesses 100 per cent of the shares in the company. Koszalin city has a population of about 110.000 inhabitants and in the Zachodnio-pomorskie region there are about 1,7...
Acquiring shares in
Acquiring shares in Polish newspaper
April 27, 2004 04:00 ET | Orkla ASA
Orkla Press now possesses 100 per cent of the shares in the company. Koszalin city has a population of about 110.000 inhabitants and in the Zachodnio-pomorskie region there are about 1,7 million...
Global Genomics Confirms Superiority of Tangerine Gene Expression Profiling
April 27, 2004 03:44 ET | Global Genomics AB
STOCKHOLM, Sweden, April 27, 2004 (PRIMEZONE) -- Global Genomics AB revealed today the exceptional performance of the company's innovative technology for gene expression profiling. In a recent study...
SCA improves distribution and production structure for tissue on the Iberian Peninsula
April 27, 2004 03:28 ET | SCA
STOCKHOLM, Sweden, April 27, 2004 (PRIMEZONE) -- As a result of the acquisition of the Nisa, Marpo, Panosa and CartoInvest companies, SCA's volumes on the Iberian tissue market have grown to...
Artimplant AB's Interim Report January 1- March 31, 2004
April 27, 2004 03:16 ET | Artimplant
STOCKHOLM, Sweden, April 27, 2004 (PRIMEZONE) -- Artimplant AB: Several New Regulatory Approvals and a Strong Financial Position -- Artimplant's net sales for the period reached SEK 1.0 million...
Active Biotech at th
Active Biotech at the 56th Annual Meeting of the American Academy of Neurology
April 27, 2004 03:15 ET | Active Biotech
Today, results from the Phase II clinical study of Active Biotech's laquinimod (SAIK-MS) for the treatment of Multiple Sclerosis (MS) are presented at the AAN (American Academy of Neurology) 56th...
Active Biotech vid 5
Active Biotech vid 56th Annual Meeting of the American Academy of Neurology
April 27, 2004 03:09 ET | Active Biotech
Active Biotech presenterar idag resultat från Fas II-studien av substansen laquinimod (SAIK-MS) för behandling av multipel skleros (MS) på den stora, årligen återkommande vetenskapliga...
Haldex Group 1st Quarter 2004
April 27, 2004 02:42 ET | Haldex
STOCKHOLM, Sweden, April 27, 2004 (PRIMEZONE) -- Haldex Group: -- Operating income amounted to 85 MSEK (9). Excluding one-time items, operating income amounted to 85 MSEK (66), an increase...
SCA Interim Report 1 January-31 March 2004
April 27, 2004 02:14 ET | SCA
STOCKHOLM, Sweden, April 27, 2004 (PRIMEZONE) -- SCA 2004:1 2003:1 2003:4 Earnings per share, SEK 4.34 6.02 ...
New Wave Group AB -- Interim Report January-March 2004
April 27, 2004 01:42 ET | New Wave Group
STOCKHOLM, Sweden, April 27, 2004 (PRIMEZONE) -- New Wave Group AB (publ): Interim Report for New Wave Group AB (publ) January-March 2004 "Continued profit increase" -- Sales increased by...
keyboard_arrow_left Previous Page
1...284904284905284906...289936
Next Page keyboard_arrow_right